by Insception Lifebank | Blog
What if treating extremely preterm babies with their own (i.e., autologous) cord blood stem cells could reduce their increased risk of brain damage and related conditions? Using a patient’s own cord blood stem cells to treat neurological conditions, like cerebral...
by Insception Lifebank | Blog
Eliza Stroh, MS, CGC, Cord Blood Clinical Specialist This July, Insception Lifebank highlights the triumphs of newborn stem cell science as we continue to spread the word about the valuable resource of cord blood and cord tissue preservation. Here, we review the...
by Insception Lifebank | Blog
Join us this July as we celebrate Cord Blood Awareness Month, a time to shine a light on the remarkable healing potential of newborn stem cells. At Insception Lifebank, we are dedicating this entire month to educating parents about the importance of...
by Insception Lifebank | Blog, blood cancer, cord blood application, FDA, Health and Wellness, Research
The FDA made history in April with its first-ever approval of an expanded cord blood product for use as a primary treatment in hematopoietic stem cell transplants (HSCT) for certain blood cancers in adults and children 12 years of age and older.1 Why is cord blood...
by Insception Lifebank | Blog
Researchers have announced that newborn stem cells played a key role in the successful treatment of pulmonary arterial hypertension (PAH) – a rare and often life-threatening disease that causes high blood pressure in the arteries of the lung and often leads to a heart...
by Ana Carolina Martins | Blog
Last year was a busy one for our group’s newborn stem cell labs and storage facilities in North America. A steady stream of families contacted our team, requesting the release of their stored newborn stem cell samples for use in stem cell transplant procedures or...